Financial conflicts of interest of clinicians making submissions to the pan-Canadian Oncology Drug Review: a descriptive study.

ABSTRACT:

Objectives

This study examines financial conflict of interest (FCOI) of clinicians who made submissions to the pan-Canadian Oncology Drug Review (pCODR), the arm of the Canadian Agency for Drugs and Technology in Health that recommends whether oncology drug indications should be publicly funded. Final reports from pCODR published between October 2016 and February 2019 were examined.

Design

Descriptive study.

Data sources

Website of pCODR.

Interventions

None.

Primary and secondary outcomes

The primary outcome is the number of submissions declaring FCOI. Secondary outcomes are the number of times where clinicians agreed and disagreed with preliminary recommendation from pCODR and the association between the distribution of individual clinicians' FCOI and p

SUBMITTER: Lexchin J 

PROVIDER: S-EPMC6661552 | biostudies-literature | 2019 Jul

REPOSITORIES: biostudies-literature